ArticleJournal of managed care & specialty pharmacy2020

Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer.

Nicole M Engel-Nitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.